Pharma BD Deal Intelligence
The 2005 Yamanouchi-Fujisawa merger of equals created Astellas Pharma, which 21 years later is a top-20 global pharma with record ¥2.1T+ revenue, powered by oncology blockbusters built on the combined legacy franchises.
Full analysis, sources & comparables →Astellas's formation announcement framed the new entity as 'A New Star in the World Pharmaceutical Industry' anchored on Prograf, Harnal/Flomax, and Vesicare,…
Post-merger, Astellas explicitly pivoted toward oncology, declaring 'oncology' a strategic focus and pursuing the OSI Pharmaceuticals acquisition for Tarceva…
Astellas Pharma 'was established through a merger of equals on April 1, 2005,' combining Fujisawa's Prograf-anchored transplant franchise with Yamanouchi's…
Source summaries from our enrichment pipeline; follow links for originals.
All 5 sources with sentiment breakdown →
The merger of equals between Yamanouchi and Fujisawa completed effective April 1, 2005, forming Astellas Pharma Inc., then Japan's #2 pharmaceutical company, via a stock-for-stock share exchange with Yamanouchi as the legal surviving entity and no cash consideration. The combination united Fujisawa's Prograf transplant franchise with Yamanouchi's Harnal urology franchise on combined 2004 predecessor revenues of roughly $7.9 billion.
The 2005 Yamanouchi-Fujisawa merger of equals created Astellas Pharma, which 21 years later is a top-20 global pharma with record ¥2.1T+ revenue, powered by oncology blockbusters built on the combined legacy franchises.
Assessment window: 15yr post-close.
| Deal | Year | Value | Outcome |
|---|---|---|---|
| Yamanouchi Pharmaceutical / Fujisawa Pharmaceutical Co. Ltd. (this deal) | 2005 | — | 92 |
| Yamanouchi Pharmaceutical / Fujisawa Pharmaceutical Co. Ltd. | 2004 | $7.6B | 84 |
| AstraZeneca PLC / KuDOS Pharmaceuticals Limited | 2005 | $210M | 98 |
| Sankyo Co., Ltd. / Daiichi Pharmaceutical Co., Ltd. | 2005 | $8.0B | 92 |
| Cephalon Inc. / Salmedix, Inc. | 2005 | $160M | 89 |
| Roche Holding AG / GlycArt Biotechnology AG | 2005 | $182M | 80 |
| Reckitt Benckiser plc / Boots Healthcare International | 2005 | $3.4B | 78 |
← Browse all deals · How we score deals
More: 2005 deals